undamentalytics Newsletter

Gonzalez Richard A: insider trades

Chief executive, Officer, Director at 2 companies we cover. No open-market purchases and 23 sales not made under a pre-set plan, reported from February 24, 2012 to March 4, 2025.

What happened after Gonzalez Richard A’s sales?

After their sales, the shares moved +6.7% against the index over 12 months on average (a negative figure means selling was the right call); 61% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Gonzalez Richard A: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 23 +3.0% +2.4% 44% 11 0.36 0.72 No reliable evidence
Sales, 12 months after the report 23 +6.7% −1.7% 61% 11 0.75 0.47 No reliable evidence
Sales, 12 months after the trade 23 +7.2% +4.3% 48% 11 0.86 0.41 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
AbbVie ABBV EXECUTIVE CHAIRMAN OF BOARD022March 4, 2014March 4, 2025
Abbott Laboratories ABT Executive Vice President01February 24, 2012February 24, 2012

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 4, 2025February 28, 2025 ABBV Sale $20,263,020 −13.1%−4.2%−0.2%
August 7, 2024August 5, 2024 ABBV Sale $12,403,580 −5.2%−14.6%−12.0%
March 1, 2024February 28, 2024 ABBV Sale $24,572,458 −12.0%+10.1%+6.3%
August 2, 2023July 31, 2023 ABBV Sale $11,674,075 +2.0%+11.6%+6.7%
December 10, 2021December 9, 2021 ABBV Sale $21,454,024 +32.8%+47.9%+50.9%
March 2, 2021March 1, 2021 ABBV Sale $18,476,427 −4.9%+30.4%+29.1%
November 12, 2020November 9, 2020 ABBV Sale $22,437,004 −1.5%−8.7%−6.3%
December 13, 2018December 11, 2018 ABBV Sale $1,495,438 −14.0%−14.7%−17.5%
March 2, 2018February 28, 2018 ABBV Sale $976,046 −14.8%−33.3%−33.0%
November 24, 2017November 21, 2017 ABBV Sale $20,512,324 +17.3%−9.6%−9.3%
August 8, 2017August 7, 2017 ABBV Sale $13,713,243 +26.2%+19.8%+19.3%
August 4, 2017August 3, 2017 ABBV Sale $6,242,300 +25.7%+19.3%+23.8%
May 23, 2017May 19, 2017 ABBV Sale $4,665,387 +7.3%+46.2%+50.6%
March 10, 2017March 8, 2017 ABBV Sale $4,627,028 +3.9%+69.3%+70.4%
June 3, 2016June 2, 2016 ABBV Sale $18,249,794 −0.9%−5.2%−10.9%
May 13, 2016May 11, 2016 ABBV Sale $2,488,200 +2.4%−7.3%−10.2%
July 31, 2015July 29, 2015 ABBV Sale $2,851,276 −13.4%−5.5%−10.1%
July 31, 2015July 29, 2015 ABBV Sale $1,775,665 −13.4%−5.5%−10.1%
April 30, 2015April 28, 2015 ABBV Sale $537,580 +9.3%−1.7%−6.4%
April 30, 2015April 8, 2015 ABBV Sale $6,659,156 +9.3%−1.7%+4.3%
April 30, 2015April 8, 2015 ABBV Sale $4,164,726 +9.3%−1.7%+4.3%
March 4, 2014March 4, 2014 ABBV Sale $245,711 +3.2%−0.8%+6.3%
February 24, 2012February 22, 2012 ABT Sale $11,737,681 +14.2%+14.9%+18.6%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Gonzalez Richard A traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.